Total-body PET: Maximizing sensitivity for clinical research and patient care
Credit: University of California, Davis RESTON, Va. - The new total-body PET/CT scanner could revolutionize our understanding and treatment of...
PharmaMar has requested the process of re-examination for Aplidin® from the EMA
(Pharmamar) PharmaMar (MSE:PHM) has announced the initiation of the re-examination process by the European Medicines Agency (EMA) for Aplidin® (plitidepsin)...
State-of-the-art MRI technology bypasses need for biopsy
Credit: UT Southwestern DALLAS - Jan. 02, 2018 - The most common type of tumor found in the kidney is...
Americans’ attitudes about science in 2017: High confidence, low visibility
ARLINGTON, Va. - Jan. 2, 2018 - Scientists and the nation's scientific enterprise remain largely invisible to the public, according...
Novel nanomedicine inhibits progression of pancreatic cancer in mice
A new Tel Aviv University study pinpoints the inverse correlation between a known oncogene -- a gene that promotes the...
Randomness a key in spread of disease, other ‘evil’
ITHACA, N.Y. - An unfortunate church dinner more than 100 years ago did more than just spread typhoid fever to...
Novel diabetes drugs sensitize cancer cells to chemotherapy agents
Scientists at Dana-Farber Cancer Institute have shown that experimental diabetes drugs can make cancer cells more vulnerable to traditional chemotherapy...
PharmaMar signs a license agreement for Aplidin® with Megapharm in Israel
PharmaMar (MSE:PHM) has announced today a commercialization and distribution license agreement with Megapharm Ltd. for the marine-derived anticancer drug Aplidin®...
Immune cells play key role in early breast cancer metastasis even before a tumor develops
(New York, NY - January 2, 2018) --Mount Sinai researchers have discovered that normal immune cells called macrophages, which reside...
Risk-based lung cancer screening may save more lives than current USPSTF guidelines
1. Risk-based lung cancer screening may save more lives than current USPSTF guidelines Abstract: http://annals.org/aim/article/doi/10.7326/M17-2067 URLs go live when the...
New guidelines on clinical trial design for patients with brain metastases
Credit: University of Colorado Cancer Center Clinical trials of new anti-cancer therapies have often excluded patients whose disease has spread...
Berry gives boost to cervical cancer therapy
Credit: University of Missouri School of Medicine According to the Centers for Disease Control and Prevention, approximately 12,000 women in...
Can e-cigarettes help smokers quit?
Credit: Sarah Pack/Hollings Cancer Center at MUSC As e-cigarettes become more popular, fewer people are taking up smoking traditional cigarettes....
A cluster of mutations in neurofibromatosis is important risk factor for severe symptoms
Credit: UAB BIRMINGHAM, Ala. - Research led by Ludwine Messiaen, Ph.D., professor of genetics at the University of Alabama at...
Carfilzomib can lead to cardiovascular toxicity in multiple myeloma patients
PHILADELPHIA - The proteasome inhibitor carfilzomib has taken on an increasing role in the treatment of multiple myeloma, but new...
Cancer overrides the circadian clock to survive
Credit: Hollings Cancer Center Tumor cells use the unfolded protein response to alter circadian rhythm, which contributes to more tumor...
Uncovering molecular targets for childhood cancer therapeutics
Credit: Department of Pediatrics, Perinatal and Maternal Medicine (Ibaraki),TMDU Study led by Tokyo Medical and Dental University (TMDU) elucidates genomic...
New understanding of why cancer cells move
Credit: University of Hawaii Cancer Center A University of Hawai'i Cancer Center researcher has identified how some cancer cells are...
Study explores impact of obesity on bone marrow cells
Credit: Credit: Cincinnati Children's CINCINNATI -New research published in the Journal of Experimental Medicine highlights the pernicious effect of obesity...
First stereotactic radiotherapy system designed for breast cancer receives FDA clearance
Baltimore, Md., Dec. 22, 2017 - The GammaPod ™ - a first-of-its kind stereotactic radiotherapy system to treat early stage...
